Clinical Trial Data on TILs in Non-Small Cell Lung Cancer (NSCLC)

Video

In the second installment of the series, Ben Creelan, MD, reviews clinical trial data and explains the rationale of using tumor-infiltrating lymphocytes (TILs) in non-small cell lung cancer (NSCLC) treatment.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
Related Content